top of page
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
IBDENC ENC
Dec 1, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizuma
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis...
0
eDoctor In
Nov 22, 2020
Pre‐treatment magnetic resonance enterography findings predict the response to TNF‐alpha inhibitors
Pre‐treatment magnetic resonance enterography findings predict the response to TNF‐alpha inhibitors in Crohn's disease Background...
0
eDoctor In
Nov 22, 2020
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentration
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine...
0
eDoctor In
Nov 15, 2020
A Post Hoc Analysis of the PAILOT Randomized Controlled Trial
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn’s...
0
IBDENC ENC
Nov 13, 2020
Combination Therapy of Adalimumab With an Immunomodulator
Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn’s...
0
eDoctor In
Nov 8, 2020
Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy
Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn’s Disease Background Gut...
0
eDoctor In
Nov 8, 2020
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID Introduction: New therapeutic options for patients...
0
eDoctor In
Nov 8, 2020
Adaptations to the British Society of Gastroenterology guidelines
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19...
0
eDoctor In
Nov 1, 2020
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized...
0
bottom of page